Reviewing Accolade (NASDAQ:ACCD) & Spree Acquisition Corp. 1 (NYSE:SHAP)

Accolade (NASDAQ:ACCD) and Spree Acquisition Corp. 1 (NYSE:SHAP) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.

Profitability

This table compares Accolade and Spree Acquisition Corp. 1’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Accolade	-40.36%	-20.74%	-11.33%
Spree Acquisition Corp. 1	N/A	-22.17%	6.72%

Institutional & Insider Ownership

85.0% of Accolade shares are owned by institutional investors. Comparatively, 9.9% of Spree Acquisition Corp. 1 shares are owned by institutional investors. 8.2% of Accolade shares are owned by company insiders. Comparatively, 58.4% of Spree Acquisition Corp. 1 shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Accolade and Spree Acquisition Corp. 1, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accolade	0	13	1	0	2.07
Spree Acquisition Corp. 1	0	0	0	0	0.00

Accolade presently has a consensus price target of $6.51, suggesting a potential downside of 7.31%. Given Accolade’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Accolade is more favorable than Spree Acquisition Corp. 1.

Valuation & Earnings

This table compares Accolade and Spree Acquisition Corp. 1″s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accolade	$446.72 million	1.29	-$99.81 million	($2.25)	-3.12
Spree Acquisition Corp. 1	N/A	N/A	$4.35 million	N/A	N/A

Spree Acquisition Corp. 1 has lower revenue, but higher earnings than Accolade.

Risk & Volatility

Accolade has a beta of 2.1, meaning that its stock price is 110% more volatile than the S&P 500. Comparatively, Spree Acquisition Corp. 1 has a beta of -0.02, meaning that its stock price is 102% less volatile than the S&P 500.

Summary

Accolade beats Spree Acquisition Corp. 1 on 7 of the 11 factors compared between the two stocks.

About Accolade

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.

About Spree Acquisition Corp. 1

Spree Acquisition Corp. 1 Limited does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the mobility-related technology businesses. The company was incorporated in 2021 and is based in Atlanta, Georgia.